Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Dr Reddy's Launches Over-The-Counter Version Of AstraZeneca's Prilosec

11th Dec 2018 06:50

NEW DELHI (Alliance News) - Dr. Reddy's Laboratories Ltd announced the launch of Omeprazole Delayed-Release Tablets, 20 mg, an over-the-counter store-brand equivalent of Prilosec OTC Tablets, 20 mg, in the US market.

OTC Omeprazole Delayed-Release Tablets, 20 mg, is a proton pump inhibitor used to treat frequent heartburn occurring two or more days per week in adults.

Prilosec is a registered trademark of AstraZeneca PLC.

Dr Reddy's Omeprazole Delayed-Release Tablets, 20 mg, is available in 14 count bottles sold in cartons of 1, 2, or 3 bottles each. Each bottle contains one complete 14-day course of treatment.


Related Shares:

Astrazeneca
FTSE 100 Latest
Value8,407.44
Change4.26